Author: Contec Healthcare
Tags:Compounding Pharmacy, Compliance, Webinar

Pharmacy Fails

Learn from experienced our Clinical Support Manager to prevent future pharmacy fails, according to USP <797> standards.
00:0300:05

Webinar Description

 

Learn from experienced our Clinical Support Manager to prevent future pharmacy fails, according to USP <797> standards.

Key Takeaways

  • Hazardous drugs are defined and categorized by NIOSH based on toxicological risk. 
  • USP <800> focuses on occupational safety and residue control in addition to sterile compounding. 
  • Cleaning, decontamination, and disinfection are distinct processes with different objectives. 
  • Hazardous drug residue may persist on surfaces and requires appropriate chemical inactivation. 
  • Implementation requires thoughtful product selection, staff training, and defined procedures. 
  • Moving from regulatory theory to practical execution is essential for sustainable compliance. 

Webinar Section Summaries

Common Compliance Failures in Sterile Compounding

The discussion highlights patterns of compliance failures observed in pharmacies, particularly related to:

 

  • USP standard misinterpretation
  • Inconsistent procedural adherence
  • Gaps between written policy and actual practice

 

Many failures are not caused by intentional disregard but by misunderstanding, complacency, or process drift over time.

 

Cleaning and Disinfection Missteps

A significant portion of pharmacy failures relates to cleaning and disinfecting practices in cleanroom environments.

 

Common issues include:

  • Incorrect disinfectant use
  • Failure to follow proper dwell times
  • Incomplete surface coverage
  • Improper product selection
  • Lack of rotation between disinfectants (where required)

 

The presenters reinforce that cleaning and disinfection are technical processes requiring correct technique—not just product application.

 

Hazardous Drug Residue and Surface Contamination Errors

The webinar also addresses failures in managing hazardous drug residue in cleanroom environments.

 

Key risks include:

  • Residue on primary engineering controls (CPECs)
  • Surface contamination in buffer and ante areas
  • Inadequate decontamination procedures

 

The panel connects hazardous drug residue management to broader compliance and safety practices, reinforcing the need for validated and consistent processes.

 

Documentation and Policy Gaps

Documentation gaps are a recurring theme in pharmacy inspection failures.

 

Examples include:

  • Incomplete cleaning logs
  • Missing training records
  • Outdated SOPs
  • Policies not aligned with actual workflow

 

The panel stresses that compliance requires not only correct action but also documented proof of that action.

 

Demonstrations and Real-World Examples

The webinar includes live demonstrations in a cleanroom studio setting to illustrate proper techniques and common mistakes.

 

These demonstrations help bridge theory and practice by showing:

  • Correct application methods
  • Surface wiping techniques
  • Product handling procedures
  • Environmental considerations

 

The goal is to provide visual and practical learning to reinforce compliance behaviors.

 

Preventing Repeat Failures Through Best Practices

The session concludes with practical recommendations for preventing pharmacy fails:

 

  • Align policies with daily workflow
  • Train staff consistently and thoroughly
  • Audit processes regularly
  • Use appropriate products and chemistries
  • Reinforce understanding of “why” behind standards

 

The presenters emphasize building a proactive compliance culture rather than reacting after inspection findings.

Behind the Scenes